Cargando…
Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes?
OBJECTIVES: To determine if dynamic CT can differentiate local progression from radioactive seed-induced peritumoral reaction (RSIPR) after brachytherapy with iodine-125 radioactive seeds (BIRS) for advanced hepatic malignancies. METHODS: Enhanced CT images of seed-implanted lesions between 2006 and...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474341/ https://www.ncbi.nlm.nih.gov/pubmed/35980429 http://dx.doi.org/10.1007/s00330-022-09074-x |
_version_ | 1784789695896485888 |
---|---|
author | Chen, Guanyu Jiao, Dechao Peng, Sheng Chen, Xi Zhang, Yanling Lin, Letao Zhong, Zhihui Li, Yong Xu, Kaihao Zhang, Fujun |
author_facet | Chen, Guanyu Jiao, Dechao Peng, Sheng Chen, Xi Zhang, Yanling Lin, Letao Zhong, Zhihui Li, Yong Xu, Kaihao Zhang, Fujun |
author_sort | Chen, Guanyu |
collection | PubMed |
description | OBJECTIVES: To determine if dynamic CT can differentiate local progression from radioactive seed-induced peritumoral reaction (RSIPR) after brachytherapy with iodine-125 radioactive seeds (BIRS) for advanced hepatic malignancies. METHODS: Enhanced CT images of seed-implanted lesions between 2006 and 2018 were retrospectively evaluated. Hounsfield units of peritumoral parenchyma were measured and assessed quantitatively. The classification, conversion, consequences, and serological indicators during follow-up were recorded and quantified. Statistical differences were analyzed using a Pearson χ(2) test. RESULTS: RSIPR was observed in 201 of 290 (69.3%) lesions (161 patients; median age, 55 years; range, 26–79 years), while local progression occurred in 53 lesions. The low density of local progression was much lower than that of RSIPR (p < 0.001), and the former did not exhibit iso-/high density in the portal or equilibrium phase. Ring-like enhancement in progressive lesions was also quite different from RSIPR. Local progression rate was lower for lesions with RSIPR than for those without RSIPR (14.9% vs 25.8%; p = 0.03), and their doses were different (397.2 Gy vs 120.3 Gy, p < 0.001). CONCLUSIONS: Radioactive seed-induced peritumoral reaction has characteristic manifestations on CT images, which is associated with a higher dose of lesions and lower local progression rate. Notably, the enhancement pattern of local progression was distinct from RSIPR and was clearly distinguishable on dynamic-enhanced CT. KEY POINTS: • Radioactive seed-induced peritumoral reaction after brachytherapy with (125)I seeds for liver malignancies has characteristic manifestations on CT images, which is associated with a higher dose of lesions (397.2 Gy vs 120.3 Gy, p < 0.001), as a focal radiation injury. • Lesions with RSIPR were less likely to develop local progression, while those without RSIPR had a higher rate of local progression (14.9% vs 25.8%; p = 0.03). • The enhancement pattern of local progression after brachytherapy was distinct from radioactive seed-induced peritumoral reaction and was clearly distinguishable on dynamic-enhanced CT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-022-09074-x. |
format | Online Article Text |
id | pubmed-9474341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-94743412022-09-16 Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes? Chen, Guanyu Jiao, Dechao Peng, Sheng Chen, Xi Zhang, Yanling Lin, Letao Zhong, Zhihui Li, Yong Xu, Kaihao Zhang, Fujun Eur Radiol Oncology OBJECTIVES: To determine if dynamic CT can differentiate local progression from radioactive seed-induced peritumoral reaction (RSIPR) after brachytherapy with iodine-125 radioactive seeds (BIRS) for advanced hepatic malignancies. METHODS: Enhanced CT images of seed-implanted lesions between 2006 and 2018 were retrospectively evaluated. Hounsfield units of peritumoral parenchyma were measured and assessed quantitatively. The classification, conversion, consequences, and serological indicators during follow-up were recorded and quantified. Statistical differences were analyzed using a Pearson χ(2) test. RESULTS: RSIPR was observed in 201 of 290 (69.3%) lesions (161 patients; median age, 55 years; range, 26–79 years), while local progression occurred in 53 lesions. The low density of local progression was much lower than that of RSIPR (p < 0.001), and the former did not exhibit iso-/high density in the portal or equilibrium phase. Ring-like enhancement in progressive lesions was also quite different from RSIPR. Local progression rate was lower for lesions with RSIPR than for those without RSIPR (14.9% vs 25.8%; p = 0.03), and their doses were different (397.2 Gy vs 120.3 Gy, p < 0.001). CONCLUSIONS: Radioactive seed-induced peritumoral reaction has characteristic manifestations on CT images, which is associated with a higher dose of lesions and lower local progression rate. Notably, the enhancement pattern of local progression was distinct from RSIPR and was clearly distinguishable on dynamic-enhanced CT. KEY POINTS: • Radioactive seed-induced peritumoral reaction after brachytherapy with (125)I seeds for liver malignancies has characteristic manifestations on CT images, which is associated with a higher dose of lesions (397.2 Gy vs 120.3 Gy, p < 0.001), as a focal radiation injury. • Lesions with RSIPR were less likely to develop local progression, while those without RSIPR had a higher rate of local progression (14.9% vs 25.8%; p = 0.03). • The enhancement pattern of local progression after brachytherapy was distinct from radioactive seed-induced peritumoral reaction and was clearly distinguishable on dynamic-enhanced CT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-022-09074-x. Springer Berlin Heidelberg 2022-08-18 2022 /pmc/articles/PMC9474341/ /pubmed/35980429 http://dx.doi.org/10.1007/s00330-022-09074-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Oncology Chen, Guanyu Jiao, Dechao Peng, Sheng Chen, Xi Zhang, Yanling Lin, Letao Zhong, Zhihui Li, Yong Xu, Kaihao Zhang, Fujun Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes? |
title | Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes? |
title_full | Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes? |
title_fullStr | Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes? |
title_full_unstemmed | Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes? |
title_short | Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes? |
title_sort | peritumoral abnormalities on dynamic-enhanced ct after brachytherapy for hepatic malignancies: local progression or benign changes? |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474341/ https://www.ncbi.nlm.nih.gov/pubmed/35980429 http://dx.doi.org/10.1007/s00330-022-09074-x |
work_keys_str_mv | AT chenguanyu peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges AT jiaodechao peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges AT pengsheng peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges AT chenxi peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges AT zhangyanling peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges AT linletao peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges AT zhongzhihui peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges AT liyong peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges AT xukaihao peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges AT zhangfujun peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges |